98%
921
2 minutes
20
Objective: To analyze the proteomic differences between mouse secondary oocytes, also known as metaphase Ⅱ oocytes (MⅡ), and the first polar bodies (PB1) using high-resolution single-cell proteomics, to identify key proteins regulating embryonic development, and to provide a molecular basis for optimizing oocyte maturation systems.
Methods: Paired samples of MⅡ ( = 5) and PB1 ( = 5) were analyzed using high-resolution single-cell mass spectrometry (timsTOF HT). Quantitative proteomics and bioinformatics approaches were employed to conduct differential protein screening and functional enrichment.
Results: Using the timsTOF HT platform, we achieved the detection of over 3000 proteins per single cell and identified 277 proteins specifically enriched in MⅡ. Gene Set Enrichment Analysis (GSEA) revealed that these MⅡ-specific proteins were significantly enriched in gene regulation and DNA damage repair pathways associated with mitochondrial energy metabolism. Cross-species GSEA comparison between human and mouse homologs demonstrated elevated expression of heat shock proteins, including Hsp90b1, Hspa5, etc., in the mTORC1 pathway in MⅡ ( < 0.05). In addition, key factors regulating cumulus complex development, such as Calr, Aldoa, etc., were significantly upregulated.
Conclusion: MⅡ strategically retains proteins essential for embryonic development through asymmetric division. The timsTOF HT platform demonstrated superior sensitivity in analyzing and identifying these proteins. According to the protein analysis results, the distribution of mTORC1 pathway proteins indicates that they play a key role in embryonic metabolism regulation. In particular, heat shock proteins facilitate protein folding and maintain endoplasmic reticulum homeostasis, thereby ensuring oocyte maturation and the embryonic developmental potential.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12207035 | PMC |
http://dx.doi.org/10.12182/20250360603 | DOI Listing |
JCI Insight
September 2025
Edinburgh Medical School: Biomedical Sciences & Euan MacDonald Centre for M, University of Edinburgh, Edinburgh, United Kingdom.
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein. Several therapeutic approaches boosting SMN are approved for human patients, delivering remarkable improvements in lifespan and symptoms. However, emerging phenotypes, including neurodevelopmental comorbidities, are being reported in some treated SMA patients, indicative of alterations in brain development.
View Article and Find Full Text PDFJCI Insight
September 2025
Department of Pharmacology, University of Michigan, Ann Arbor, United States of America.
Cardiac hypertrophy is a common adaptation to cardiovascular stress and often a prelude to heart failure. We examined how S-palmitoylation of the small GTPase, Ras-related C3 botulinum toxin substrate 1 (Rac1), impacts cardiomyocyte stress signaling. Mutation of the cysteine-178 palmitoylation site impaired activation of Rac1 when overexpressed in cardiomyocytes.
View Article and Find Full Text PDFMol Pharm
September 2025
Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-Ku, Kyoto 606-8501, Japan.
Fibroblast activation protein (FAP) is an attractive biomarker for tumor-targeting radioligands. While [Ga]Ga-FAPI-46 is a promising FAP-targeting radioligand for cancer diagnosis, clinical application of [Lu]Lu-FAPI-46 for targeted radionuclide therapy is limited due to its insufficient tumor retention. Albumin binder (ALB) including 4-(-iodophenyl)butyric acid is widely utilized to improve tumor accumulation of radioligands.
View Article and Find Full Text PDFJ Clin Invest
September 2025
The University of Texas at Austin, Austin, United States of America.
Background: Following SARS-CoV-2 infection, ~10-35% of COVID-19 patients experience long COVID (LC), in which debilitating symptoms persist for at least three months. Elucidating biologic underpinnings of LC could identify therapeutic opportunities.
Methods: We utilized machine learning methods on biologic analytes provided over 12-months after hospital discharge from >500 COVID-19 patients in the IMPACC cohort to identify a multi-omics "recovery factor", trained on patient-reported physical function survey scores.
J Clin Invest
September 2025
Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.
Understanding the genetic causes of diseases affecting pancreatic β cells and neurons can give insights into pathways essential for both cell types. Microcephaly, epilepsy and diabetes syndrome (MEDS) is a congenital disorder with two known aetiological genes, IER3IP1 and YIPF5. Both genes encode proteins involved in endoplasmic reticulum (ER) to Golgi trafficking.
View Article and Find Full Text PDF